ABSI
Absci Corp
NASDAQ · Healthcare · Biotechnology · US
$9.65
+4.10%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- $697.6K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.19
- Revenue actual
- $300.0K
- Revenue estimate
- $919.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -9.6%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $15
- PT range
- $11 – $17
- Analysts
- 5
5 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.19 | -$0.18 | Beat 5.77% | $300.0K |
| May 7, 2026 | -$0.20 | -$0.19 | Beat 5.00% | $215.0K |
| Mar 24, 2026 | -$0.16 | -$0.23 | Miss -43.75% | $650.0K |
| Nov 12, 2025 | -$0.19 | -$0.20 | Miss -5.26% | $378.0K |
| Aug 12, 2025 | -$0.19 | -$0.24 | Miss -26.32% | $593.0K |
| Mar 18, 2025 | -$0.22 | -$0.25 | Miss -13.64% | $665.0K |
| Aug 14, 2024 | -$0.19 | -$0.22 | Miss -15.79% | $1.3M |
| Mar 21, 2024 | -$0.23 | -$0.25 | Miss -8.70% | $338.0K |
| Nov 14, 2023 | -$0.23 | -$0.24 | Miss -4.35% | $744.0K |
| Aug 14, 2023 | -$0.24 | -$0.27 | Miss -12.50% | $3.4M |
| May 15, 2023 | -$0.24 | -$0.26 | Miss -8.33% | $1.3M |
| Aug 11, 2022 | -$0.32 | -$0.32 | In line | $1.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026